Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

A. Sheikh | O. Mayora | T. To | D. Caillaud | R. Picard | B. Yawn | L. Bertorello | X. Basagaña | J. Pépin | M. Barbagallo | L. Rodríguez-Mañas | A. Boner | H. Schünemann | E. Novellino | L. Boulet | J. Bousquet | T. Zuberbier | C. Bachert | P. Bousquet | J. Brożek | G. Canonica | T. Casale | P. Demoly | R. Gerth van Wijk | K. Ohta | E. Bateman | Á. Cruz | O. Spranger | S. Bonini | P. Camargos | K. Carlsen | N. Chavannes | S. Durham | J. Fonseca | T. Haahtela | O. Kalayci | M. Kowalski | D. Larenas-Linnemann | J. Li | Y. Mohammad | J. Mullol | G. Passalacqua | K. Rabe | R. Pawankar | D. Ryan | B. Samoliński | F. Simons | E. Valovirta | A. Yorgancioglu | O. Yusuf | I. Agache | I. Annesi-Maesano | B. Beghé | J. Bouchard | Y. Chen | A. Chuchalin | A. Custovic | J. Denburg | H. Douagui | R. Ėmužytė | M. Humbert | S. Johnston | P. Keith | P. Kuna | L. Le | B. Lipworth | B. Mahboub | G. Marshall | S. Mavale-Manuel | E. Meltzer | M. Morais‐Almeida | K. Nékám | Y. Okamoto | S. Ouédraogo | S. Palkonen | T. Popov | D. Price | J. Rosado-Pinto | G. Scadding | T. Sooronbaev | O. Vandenplas | G. Viegi | D. Wang | M. Wickman | D. Williams | H. Zar | M. Zernotti | N. Zhong | D. Larenas-Linnemann | A. Muraro | A. Courbis | T. Vasankari | R. Murray | S. Arnavielhe | D. Caimmi | A. Bedbrook | M. van Eerd | G. Dray | K. Bergmann | S. Bosnic-Anticevich | C. Bucca | W. Carr | L. Klimek | V. Kvedarienė | P. Tomazic | M. Triggiani | A. Valiulis | M. Wagenmann | P. Devillier | P. Hellings | G. de Carlo | T. Keil | R. Naclerio | S. Walker | C. Akdis | C. Cingi | M. Illario | G. Joos | B. Pugin | D. Somekh | N. Papadopoulos | M. Jutel | O. Pfaar | R. Bourret | T. Camuzat | D. Laune | A. Didier | E. Prokopakis | J. Sunyer | N. Roche | K. Lødrup Carlsen | K. Bergmann | C. Bindslev‐Jensen | R. Dubakiene | W. Fokkens | P. Panzner | A. Romano | P. Schmid‐Grendelmeier | A. Todo-Bom | R. Valenta | S. Dahlén | K. Chung | S. Montefort | M. Bonini | T. Bieber | V. Siroux | W. Aberer | N. Khaltaev | P. Yiallouros | P. Lieberman | Y. Dauvilliers | P. Kardas | E. Bel | R. Puy | A. Gamkrelidze | G. D'Amato | L. Cecchi | M. Ebisawa | E. Jassem | J. Garcia-Aymerich | I. Pali-Schöll | X. Rodó | L. Namazova-Baranova | F. Raciborski | D. Solé | R. Stelmach | I. Pin | J. Rizzo | H. Pinnock | I. Tsiligianni | A. Bush | G. Rolla | M. Kupczyk | H. Blain | F. Blasi | N. Scichilone | U. Darsow | H. Sagara | F. Mihălțan | G. Ciprandi | A. Mota-Pinto | M. Veríssimo | J. Malva | S. Forti | M. Sondermann | V. Briedis | D. Maier | A. Fiocchi | F. de Blay | N. Guldemond | A. Lipiec | I. Momas | J. Just | N. Rosário | H. Schunemann | R. Louis | M. Thibaudon | G. Iaccarino | P. Eklund | M. Sanchez‐Borges | I. Ansotegui | M. Rottem | A. Vatrella | A. Papi | D. Chu | J. Hajjam | A. Magnan | I. Baroni | M. Nalin | Y. Okamoto | R. Roller-Wirnsberger | K. Okubo | E. Paulino | C. Bárbara | G. Brusselle | B. Gemicioğlu | R. Buhl | F. Braido | I. Baiardini | S. Waserman | M. Maurer | L. Bjermer | K. Jung | S. Pedersen | F. Amat | M. Khaitov | N. Di Carluccio | M. Persico | M. Rizzo | E. Krzych-Fałta | I. Kull | V. Cardona | M. Ventura | T. Werfel | K. Bennoor | N. Papadopoulos | R. Nadif | L. Zhang | E. Menditto | J. Kleine‐Tebbe | D. Wallace | A. Kalyoncu | P. Potter | F. Ródenas | J. Sisul | E. Jares | M. Akdis | C. Pitsios | A. Mair | M. Sova | M. Masjedi | U. Trama | E. van Ganse | M. Bedolla-Barajas | J. Hourihane | M. Guzmán | D. Plavec | J. Salimäki | J. Maspero | C. Rolland | T. Chivato | L. Nogueira-Silva | Y. El-Gamal | J. Gereda | A. Nieto | R. Chiron | W. Pohl | H. Neffen | C. Suppli Ulrik | M. Román Rodríguez | R. Almeida | M. Zidarn | M. Kuitunen | S. Reitsma | P. Bonniaud | M. Przemęcka | C. Robalo-Cordeiro | B. Milenković | C. Zubrinich | C. Stellato | R. Gómez | Tuula Vasankari | M. Dykewicz | C. Panaitescu | J. Farrell | J. Karjalainen | A. Farsi | W. Czarlewski | J. Ivancevich | S. Toppila-Salmi | R. Stukas | F. Avolio | E. de Manuel Keenoy | E. Costa | A. Cepeda | G. Levato | A. Białoszewski | J. Luna-Pech | J. Gálvez-Romero | A. Asarnoj | E. Eller | E. Mathieu‐Dupas | D. Conforti | D. Deleanu | F. Caballero-Fonseca | S. Becker | W. Czarlewski | I. Bossé | J. Fontaine | I. Kaidashev | O. Lourenço | J. C. de Sousa | A. Carriazo | D. Dokic | A. Pereira | J. Rimmer | M. Westman | I. Skrindo | H. Park | E. Burte | S. G. González Díaz | P. Manning | A. Valero | R. O'Hehir | G. Canonica | S. Białek | R. Monti | R. Mösges | S. Shamai | E. Melén | G. De Vries | J. Mullol | C. Brightling | R. Buonaiuto | C. Cartier | E. Chkhartishvili | E. Colgan | J. da Silva | M. Gotua | E. Melo-Gomes | N. Miculinić | G. Moda | M. Mogica-Martínez | L. Münter | L. Napoli | A. Neou | G. Onorato | J. Phillips | F. Portejoie | G. Vezzani | F. Viart | P. Wroczynski | M. Bewick | D. Rivero-Yeverino | E. Rodríguez-Zagal | P. Schmidt-Grendelmeier | T. Dedeu | R. Anglés | S. Arnavielle | E. Asayag | H. Arshad | E. Bacci | B. Barreto | M. Benson | A. Blua | M. Bochenska Marciniak | I. Bogus-Buczynska | C. S. Bosnic-Anticevich | M. B. Burguete Cabañas | G. Canfora | G. Castellano | M. Ciaravolo | A. Cicerán | A. C. Carvalho Coehlo | L. Colas | J. Coll | R. M. Cortes-Grimaldo | F. Corti | M. C. Costa-Domínguez | L. Cox | M. Crescenzo | C. Dario | M. de Fátima Emerson | B. D. De Martino | S. Di Capua Ercolano | M. Domínguez-Silva | J. Ferrero | J. Fuentes-Pérez | C. Y. García-Cobas | M. Garcia-Cruz | S. Genova | J. Gómez-Vera | I. Grisle | M. Guidacci | Z. Gutter | L. Hernández | Y. R. Huerta-Villalobos | P. Lacwik | D. Lauri | J. Lavrut | M. Lessa | I. Majer | E. Mandajieva | J. M. Matta Campos | A. Matos | M. Medina-Ávalos | J. Mercier | D. Mora Bogado | F. Morato-Castro | P. Moura Santo | V. Niedeberger | M. Noguès | T. D. Nyembue | C. Odzhakova | M. Ortega Cisneros | B. Pigearias | A. Pozzi | R. E. Pulido Ross | R. Rajabian-Soderlund | I. Ribeirinho | M. Rodríguez González | S. R. Rodrigues Valle | M. Romano | J. Sastre-Dominguez | F. Serpa | M. Sierra | M. Sørensen | M. Sorlini | J. Stróżek | A. Szylling | J. Tebyriçá | M. Urrutia-Pereira | M. van Hague | D. Vicheva | T. Vontetsianos | S. Williams | N. Wilson | J. Wright | P. Yakovliev | A. Zurkuhlen | G. Christoff | N. Pham‐Thi | J. Ferreira de Mello | G. du Toit | R. O'Hehir | A. Fink-Wagner | Z. Ispayeva | G. de Feo | J. Anto | P. Carreiro‐Martins | J. M. Fuentes Pèrez | M. Dykewick | J. P. W. W. I. C. A. M. M. R. R. F. R. I. I. J. J. M. Bousquet Hellings Aberer Agache Akdis Akdis Al | M. Aliberti | M. Calderon | N. P. Motta Rubina | I. Zhanat | J. Máspero | R. M. Cortés-Grimaldo | J. M. Fuentes Pérez | A. Sheikh | N. Miculinic | K. Chung | J. Bousquet | M. Sánchez-Borges

[1]  F. Tarazona-Santabalbina,et al.  Enfermedad por coronavirus 2019 (COVID-19) y edadismo: revisión narrativa de la literatura , 2020, Revista Española de Geriatría y Gerontología.

[2]  G. Spencer,et al.  Sustainable development goals for health promotion: a critical frame analysis. , 2019, Health promotion international.

[3]  J. Bousquet,et al.  Association between asthma, rhinitis, and conjunctivitis multimorbidities with molecular IgE sensitization in adults , 2019, Allergy.

[4]  A. Sheikh,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. , 2019, The Journal of allergy and clinical immunology.

[5]  J. Bousquet,et al.  Disentangling the heterogeneity of allergic respiratory diseases by latent class analysis reveals novel phenotypes , 2018, Allergy.

[6]  Rosalind W. Picard,et al.  MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence , 2018, Clinical and Translational Allergy.

[7]  Daniel Laune,et al.  POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project , 2018, Clinical and Translational Allergy.

[8]  A. Sheikh,et al.  Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study , 2018, Allergy.

[9]  J. Bousquet,et al.  Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber. , 2018, The journal of allergy and clinical immunology. In practice.

[10]  Boleslaw Samolinski,et al.  Electronic Clinical Decision Support System for allergic rhinitis management: MASK e‐CDSS , 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  A. Sheikh,et al.  Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study , 2018, Allergy.

[12]  J. Bousquet,et al.  [2017 Brussels Agreement for Latin America: an initiative of the GARD and Slaai]. , 2018, Revista alergia Mexico.

[13]  Rosalind W. Picard,et al.  Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study , 2018, The World Allergy Organization journal.

[14]  J. Bousquet,et al.  The asthma‐rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults , 2018, Allergy.

[15]  R. Murray,et al.  [MASK (Mobile Airways Sentinel networK) in Turkey-the ARIA integrated mobile solution for allergic rhinitis and asthma multimorbidity]. , 2018, Tuberkuloz ve toraks.

[16]  C. Janson,et al.  Having concomitant asthma phenotypes is common and independently relates to poor lung function in NHANES 2007–2012 , 2018, Clinical and Translational Allergy.

[17]  A. Sheikh,et al.  The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study , 2018, Allergy.

[18]  O. Mayora,et al.  Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project) , 2018, Allergy.

[19]  J. Bousquet,et al.  European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017) , 2017, Clinical and Translational Allergy.

[20]  David Pencheon,et al.  Sustainable Development Goals (SDGs), and their implementation: A national global framework for health, development and equity needs a systems approach at every level. , 2017, British medical bulletin.

[21]  A. Sheikh,et al.  CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report , 2017, Clinical and Translational Allergy.

[22]  Juan Carlos Ivancevich,et al.  Resumen ejecutivo de ARIA 2016: vías integradas de atención para la medicina predictiva a lo largo del ciclo de vida en Argentina , 2017 .

[23]  P. Cullinan,et al.  Impact of Rhinitis on Work Productivity: A Systematic Review. , 2017, The journal of allergy and clinical immunology. In practice.

[24]  Joaquim Mullol,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision , 2017, The Journal of allergy and clinical immunology.

[25]  J. Bousquet,et al.  Work productivity in rhinitis using cell phones: The MASK pilot study , 2017, Allergy.

[26]  O. Mayora,et al.  Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  D. Ryan,et al.  Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement , 2017, Allergy.

[28]  A. Sheikh,et al.  The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire Using Mobile Technology: The MASK Study. , 2017, Journal of investigational allergology & clinical immunology.

[29]  W. Fokkens,et al.  Endotype-driven treatment in chronic upper airway diseases , 2017, Clinical and Translational Allergy.

[30]  P Demoly,et al.  Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK‐rhinitis study , 2017, Allergy.

[31]  J. Bousquet,et al.  Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report , 2017, Clinical and Translational Allergy.

[32]  J. Bousquet,et al.  [ARIA 2016 executive summary: integrated care pathways for predictive medicine across the life cycle]. , 2017, Tuberkuloz ve toraks.

[33]  I. Agache,et al.  European symposium on the awareness of allergy: report of the promotional campaign in the European Parliament (26–28 April 2016) , 2017, Allergy.

[34]  Todor A Popov,et al.  ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle , 2016, Clinical and Translational Allergy.

[35]  D. Postma,et al.  Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story , 2016, Allergy.

[36]  Todor A Popov,et al.  MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. , 2016, The Journal of allergy and clinical immunology.

[37]  D. Postma,et al.  Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) , 2016, Clinical and Translational Allergy.

[38]  S. Nyenhuis,et al.  Rhinitis in the Elderly. , 2016, Immunology and allergy clinics of North America.

[39]  J. Bousquet,et al.  AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation , 2016, European Respiratory Journal.

[40]  D. Stanley.  Integrated Care Pathways for Airway Diseases. , 2016, The Lancet. Respiratory medicine.

[41]  J. Bousquet,et al.  European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015). , 2015, Rhinology.

[42]  Todor A Popov,et al.  MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. , 2015, Allergy.

[43]  Y. Saeys,et al.  Phenotyping asthma, rhinitis and eczema in MeDALL population‐based birth cohorts: an allergic comorbidity cluster , 2015, Allergy.

[44]  D. Postma,et al.  Developmental determinants in non-communicable chronic diseases and ageing , 2015, Thorax.

[45]  H. Schünemann,et al.  Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study. , 2014, The Journal of allergy and clinical immunology.

[46]  T. To,et al.  The Global Alliance against Respiratory Diseases (GARD) Country Report , 2014, Primary care respiratory journal : journal of the General Practice Airways Group.

[47]  J. Bousquet,et al.  Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal , 2013, Allergy.

[48]  B. Samoliński,et al.  Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing , 2013, Allergy.

[49]  J. Bousquet,et al.  Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? , 2013, Allergy.

[50]  Todor A Popov,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. , 2012, The Journal of allergy and clinical immunology.

[51]  J. Bousquet,et al.  Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union , 2012, Allergy.

[52]  J. Bousquet,et al.  Council of the European Union conclusions on chronic respiratory diseases in children , 2012, The Lancet.

[53]  G. Canonica,et al.  Clinical and cytologic characteristics of allergic rhinitis in elderly patients. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[54]  D. Postma,et al.  Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA2LEN – ARIA Position Paper , 2012, International Archives of Allergy and Immunology.

[55]  K. Ohta,et al.  Prevalence and impact of rhinitis in asthma. SACRA, a cross‐sectional nation‐wide study in Japan , 2011, Allergy.

[56]  J. Mullol,et al.  Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: The PEDRIAL study , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[57]  P. Bossuyt,et al.  Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3. The GRADE approach to developing recommendations , 2011, Allergy.

[58]  W. Busse,et al.  Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. , 2010, The Journal of allergy and clinical immunology.

[59]  B. Yawn,et al.  Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper , 2010 .

[60]  Holger J Schünemann,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. , 2010, The Journal of allergy and clinical immunology.

[61]  J. Bousquet,et al.  Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma , 2010, Allergy.

[62]  J. Mullol,et al.  Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort study. , 2010, Rhinology.

[63]  M. Rottem.  [Allergic rhinitis and its impact on asthma]. , 2010, Harefuah.

[64]  P. Van cauwenberge,et al.  The ARIA guidelines in specialist practice: a nationwide survey. , 2010, Rhinology.

[65]  J. Bousquet,et al.  Allergic rhinitis and its impact on asthma update (ARIA 2008)--western and Asian-Pacific perspective. , 2009, Asian Pacific journal of allergy and immunology.

[66]  J. Bousquet,et al.  [Allergic rhinitis and its impact upon asthma--update (ARIA 2008). Romanian perspective]. , 2009, Pneumologia.

[67]  J. Bousquet,et al.  Unmet needs in severe chronic upper airway disease (SCUAD). , 2009, The Journal of allergy and clinical immunology.

[68]  G H Guyatt,et al.  Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies , 2009, Allergy.

[69]  B. Brunekreef,et al.  GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’ , 2009, Allergy.

[70]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations in clinical practice guidelines , 2009, Allergy.

[71]  J. Bousquet,et al.  Implementation of Guidelines for Allergic Rhinitis in Specialist Practices , 2009, International Archives of Allergy and Immunology.

[72]  R. Pawankar,et al.  Allergic rhinitis and co-morbid asthma: perspective from India -- ARIA Asia-Pacific Workshop report. , 2009, Asian Pacific journal of allergy and immunology.

[73]  Carlos E. Baena Cagnani,et al.  Actualización de rinitis alérgica y su impacto en el asma (ARIA 2008). La perspectiva latinoamericana , 2009 .

[74]  S. Shahi,et al.  Aeroallergens in clinical practice of allergy in India- ARIA Asia Pacific Workshop report. , 2008, Asian Pacific journal of allergy and immunology.

[75]  R. Espínola,et al.  Incremento del conocimiento de las guías ARIA y GINA 2006 para médicos generales mediante una intervención educativa , 2008 .

[76]  J. Bousquet,et al.  [Allergic rhinitis and its impact on asthma update (ARIA 2008). The Turkish perspective]. , 2008, Tuberkuloz ve toraks.

[77]  Luo Zhang,et al.  [An introduction of allergic rhinitis and its impact on asthma (ARIA) 2008 update]. , 2008, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[78]  T. Zuberbier,et al.  ARIA‐suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN Review , 2008, Allergy.

[79]  G. Viegi,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.

[80]  J Bousquet,et al.  Methodology for development of the Allergic Rhinitis and its Impact on Asthma Guideline 2008 update , 2007, Allergy.

[81]  R. de Marco,et al.  Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma , 2007, Allergy.

[82]  P. Bousquet,et al.  ARIA (Allergic Rhinitis and Its Impact on Asthma) Classification of Allergic Rhinitis Severity in Clinical Practice in France , 2007, International Archives of Allergy and Immunology.

[83]  J Bousquet,et al.  Global Alliance against Chronic Respiratory Diseases , 2007, European Respiratory Journal.

[84]  J. Bousquet,et al.  Original article: Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines , 2007, Allergy.

[85]  R. Dubakiene,et al.  Pharmacologic and anti‐IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN) , 2006, Allergy.

[86]  P. Palange,et al.  Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN , 2006, Allergy.

[87]  D. Price,et al.  ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. , 2006, The Journal of allergy and clinical immunology.

[88]  J. Bousquet,et al.  The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine , 2004, Allergy.

[89]  D. Plavec.  [ARIA--one airway, one disease: what links our research to the concept?]. , 2004, Arhiv za higijenu rada i toksikologiju.

[90]  P. Howarth,et al.  ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy , 2004, Allergy.

[91]  J. Bousquet,et al.  Validation of the classification of ARIA (allergic rhinitis and its impact on asthma) , 2003, Allergy.

[92]  J. Bousquet,et al.  Requirements for medications commonly used in the treatment of allergic rhinitis , 2003, Allergy.

[93]  J. Bousquet,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) , 2003 .

[94]  J. Kemp,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA): In collaboration with the World Health Organization , 2002 .

[95]  J Bousquet,et al.  Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. , 2001, Bulletin of the World Health Organization.

[96]  J. Bousquet,et al.  Allergic rhinitis and its impact on asthma. , 2001, The Journal of allergy and clinical immunology.

[97]  J. Bousquet,et al.  Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. , 1994, The Journal of allergy and clinical immunology.

[98]  O. Mayora,et al.  Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - Reference Site Twinning (EIP on AHA). , 2017 .

[99]  J. Bousquet,et al.  [ARIA 2016 executive summary: Integrated care pathways for predictive medicine throughout the life cycle in Argentina]. , 2017, Revista alergia Mexico.

[100]  P. Demoly,et al.  The ARIA score of allergic rhinitis using mobile technology correlates with quality-of-life: The MASK study , 2017 .

[101]  H. Schünemann,et al.  [ARIA (Allergic Rhinitis and its Impact on Asthma) achievements in 10 years and future needs]. , 2012, Tuberkuloz ve toraks.

[102]  Bateman,et al.  Development and implementation of guidelines in allergic rhinitis – an ARIA-GA 2 LEN paper , 2010 .

[103]  J. Bousquet,et al.  [Allergic rhinitis update and its impact on asthma (ARIA 2008). Latin American perspective]. , 2009, Revista alergia Mexico.

[104]  J. Bousquet,et al.  [Allergic rhinitis and its impact on asthma (ARIA update 2008). The Austrian perspective]. , 2009, Wiener medizinische Wochenschrift.

[105]  J. Bousquet,et al.  Allergic Rhinitis and its Impact on Asthma update (ARIA 2008). The perspective from Spain. , 2008, Journal of investigational allergology & clinical immunology.

[106]  J. Bousquet,et al.  Allergic Rhinitis and its impact on asthma update (ARIA 2008). The Belgian perspective. , 2008, B-ENT.

[107]  N. H. Méndez,et al.  [Increased knowledge of ARIA and GINA guides 2006 to general physicians by an educational intervention]. , 2008, Revista alergia Mexico.

[108]  J. Bousquet,et al.  Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. , 2007 .

[109]  [Up-to-date Mexican consensus in Allergic Rhinitis and its Impact on Asthma, 2005. ARIA]. , 2005, Revista alergia Mexico.

[110]  C. Bachert,et al.  The WHO ARIA (allergic rhinitis and its impact on asthma) initiative. , 2003, Chemical immunology and allergy.

[111]  C. Bachert.  Allergic rhinitis and its impact on asthma (ARIA)--what does it mean for the future of SIT? , 2003, Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M.

[112]  P. Cauwenberge.  Allergic Rhinitis and its Impact on Asthma (ARIA) , 2002 .